Clinical Trial Update: Pilot Study of the Safety and Efficacy of Carvedilol in Pulmonary Arterial Hypertension [Phase 1, Phase 2]

View source ↗

Summary

A pilot Phase 1/2 study evaluating the safety and efficacy of carvedilol in pulmonary arterial hypertension, with results posted in June 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• CARVEDILOL (Carvedilol)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Pulmonary Arterial Hypertension | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-06-08